Dubai, UAE: Dubai Science Park, a science-focused business community, hosted its second Advance Health networking event in partnership with OPEN Health, a medical communications and market access agency, Synapse Medical Services, a healthcare administration company, and Connect Communications, a strategic healthcare communications agency, to address the latest developments in rare diseases.
Attending the event as part of an expert panel discussion were Dr Fatma Al Bastaki, Board Member at UAE Rare Disease Society and Consultant Pediatrician at Dubai Health Authority, Dr Fatma Al Jasmi, Member of UAE Rare Disease Society, Consultant at Tawam Hospital, and Associate Professor at UAE University, Ashraf Salama, Head of GCC and Yemen at Sanofi Genzyme, Manar Al Nahar, Middle East Country Manager at Alexion and Gavin Jones, Director of Rare Diseases at OPEN Health.
Welcoming the networking opportunity for industry professionals, Marwan Abdulaziz Janahi, Managing Director of Dubai Science Park and Chairing Member of the Pharmaceuticals and Medical Equipment Taskforce of the Dubai Industrial Strategy 2030, said: “With rare diseases, it is imperative to build a strong communication network among industry players and raise greater awareness about the various conditions and treatments. As part of its commitment, Dubai Science Park prioritises the contribution of its expertise to the rare disease landscape. Following the signing of our agreement with Sanofi in 2017, we have launched several working groups to help assess the current rare disease landscape in the UAE, and look at ways in which the conditions can be effectively tackled.”
Dr Fatma Al Jasmi mentioned that the incidence of rare diseases in the region is markedly high. Key challenges in rare diseases include delayed diagnosis, inadequate diagnostic facilities, and coverage of treatments.
The panel discussion highlighted some of the progress to date, including a newborn screening program to facilitate detection of certain rare diseases. The panel highlighted the critical need for all of the stakeholders to work together to address these challenges and reduce the burden of rare diseases.
Sahar Samara, Managing Director of OPEN Health Dubai, said: “Improving patient outcomes in rare diseases is a priority within the healthcare sector. This informative and engaging meeting provided rich insights into how we can make meaningful progress on this front in the UAE. Collaboration between all stakeholders is essential if we are to make a difference.”
Dubai Science Park periodically hosts thought leadership events that connect decision-makers from the government, academia and industry for the benefit of the residents. The destination’s upcoming flagship event, the 10thGreen Leadership Series that seeks to promote a sustainable and low-carbon future.
-Ends-
Company Profile Dubai Science Park
Founded in 2005, Dubai Science Park (DSP) is a vibrant, holistic, science-focused community, dedicated to supporting entrepreneurs, SMEs and MNEs. Since its inception, the community has grown to more than 350 companies, employing over 3,600 professionals in the sciences, energy and environmental sectors.
Designed specifically for the needs of businesses and professionals who work in sciences, DSP fosters an environment that supports scientific research, creativity and innovation. By providing ample office and laboratory space, a robust infrastructure and a vibrant community for residents, DSP ensures a supportive eco-system for businesses and professionals to flourish.
Dubai Science Park aims to play a significant role by facilitating a more sustainable and self-sufficient future that maximises the use of indigenous resources and talent. DSP will achieve this by supporting innovation in the sciences by fostering growth and change in the areas of human science, plant science, material science, environmental science and energy science.
For more information: www.dsp.ae
For media inquiries, please contact:
Christoph Diesch
APCO Worldwide
cdiesch@apcoworldwide.com
+971 (0) 55 134 0892
Anisha Pamnani
APCO Worldwide
apamnani@apcoworldwide.com
+971 (0) 55 103 8741
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
